{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T13:11:10Z","timestamp":1778245870265,"version":"3.51.4"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"FIS-IMSS\/PROT\/G11\/929"},{"name":"FUNDACION IMSS"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.biopha.2017.10.024","type":"journal-article","created":{"date-parts":[[2017,10,12]],"date-time":"2017-10-12T15:04:19Z","timestamp":1507820659000},"page":"320-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Anxiolytic effect of fatty acids and terpenes fraction from Aloysia triphylla: Serotoninergic, GABAergic and glutamatergic implications"],"prefix":"10.1016","volume":"96","author":[{"given":"Enrique","family":"Jim\u00e9nez-Ferrer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayra Alejandra","family":"Santill\u00e1n-Urquiza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elian","family":"Alegr\u00eda-Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Zamilpa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Noguer\u00f3n-Merino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Tortoriello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"Navarro-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarita","family":"Avil\u00e9s-Flores","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Macrina","family":"Fuentes-Mata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maribel","family":"Herrera-Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2017.10.024_bib0005","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1745-4530.2007.00100.x","article-title":"Evaluation of global yield, composition, antioxidant activity and cost of manufacturing of extracts from lemon verbena (Aloysia triphylla [l\u2019h\u00e9rit.] britton) and mango (Mangifera indica.) leaves","volume":"30","author":"Meireles","year":"2007","journal-title":"J. Food Process Eng."},{"key":"10.1016\/j.biopha.2017.10.024_bib0010","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1080\/10412905.2008.9700028","article-title":"Characterization of Lemon Verbena (Aloysia citriodora Palau) from Argentina by the essential oil","volume":"20","author":"Di Leo Lira","year":"2008","journal-title":"J. Essent. Oil Res."},{"key":"10.1016\/j.biopha.2017.10.024_bib0015","series-title":"Plantas Aprobadas En Colombia, Segunda Edici\u00f3n","author":"Fonnegra","year":"2007"},{"key":"10.1016\/j.biopha.2017.10.024_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1080\/10412905.2005.9698835","article-title":"Composition of the essential oils from flowers and leaves of vervain [Aloysia triphylla (L\u2019Herit.) britton] grown in Portugal","volume":"17","author":"Santos-Gomes","year":"2005","journal-title":"J. Essent. Oil Res."},{"key":"10.1016\/j.biopha.2017.10.024_bib0025","series-title":"Aceites Esenciales De La Rep\u00fablica Argentina","author":"Fester","year":"1961"},{"key":"10.1016\/j.biopha.2017.10.024_bib0030","unstructured":"Bandoni, A.L., nigueral, C., Associaci\u00f3, C., 2003. Los Recursos vegetales arom\u00e1ticos en Latinoam\u00e9rica su aprovechamiento industrial para la producci\u00f3n de aromas y sabores."},{"key":"10.1016\/j.biopha.2017.10.024_bib0035","series-title":"Atlas De Las Plantas De La Medicina Tradicional Mexicana","author":"Argueta","year":"1994"},{"key":"10.1016\/j.biopha.2017.10.024_bib0040","first-page":"449","article-title":"Plants employed in the treatment of anxiety and insomnia: II: Effect of infusions of Aloysia triphylla on experimental anxiety in normal volunteers","volume":"61","author":"Wannmacher","year":"1990","journal-title":"Fitoterapia"},{"key":"10.1016\/j.biopha.2017.10.024_bib0045","unstructured":"WHO. World Healt Organization. The World Health Report. 2016. In: Mental Health: New Understanding, 2004. New Hope. Investing in treatment for depression and anxiety leads to fourfold return. Geneve."},{"key":"10.1016\/j.biopha.2017.10.024_bib0050","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/mpr.1444","article-title":"The regional distribution of anxiety disorders: implications for the global burden of disease study, 2010","volume":"23","author":"Baxter","year":"2014","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10.1016\/j.biopha.2017.10.024_bib0055","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuropharm.2008.07.045","article-title":"GABA a receptor: subtypes provide diversity of function and pharmacology","volume":"56","author":"Olsen","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.10.024_bib0060","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.conb.2007.04.001","article-title":"GABA(b) receptors: synaptic functions and mechanisms of diversity","volume":"17","author":"Ulrich","year":"2007","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.biopha.2017.10.024_bib0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use: a meta-analysis","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.biopha.2017.10.024_bib0070","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/S0022-3565(24)29466-0","article-title":"Pentylenetetrazole-induced inhibition of recombinant gamma-aminobutyric acid type a (GABA(a)) receptors: mechanism and site of action","volume":"298","author":"Huang","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2017.10.024_bib0075","series-title":"GABA Neurotransmission: An Overview. Handbook of Neurochemistry and Molecular Neurobiology. Neurotransmitter System","first-page":"2013","article-title":"Chapter 9","author":"Schousboe","year":"2008"},{"key":"10.1016\/j.biopha.2017.10.024_bib0080","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT 1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.10.024_bib0085","first-page":"222","article-title":"Combination treatment with benzodiazepines and SSRIs for comorbid anxiety and depression: a review","volume":"10","author":"Dunlop","year":"2008","journal-title":"Prim. Care Compan. J. Clin. Psychiatry"},{"key":"10.1016\/j.biopha.2017.10.024_bib0090","doi-asserted-by":"crossref","first-page":"15049","DOI":"10.1073\/pnas.95.25.15049","article-title":"Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice","volume":"95","author":"Heisler","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.biopha.2017.10.024_bib0095","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2012.04.032","article-title":"Buspirone: what is it all about?","volume":"1461","author":"Loane","year":"2012","journal-title":"Brain Res."},{"key":"10.1016\/j.biopha.2017.10.024_bib0100","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1471-4159.1993.tb03217.x","article-title":"Serotonin 5-HT 1A autoreceptor blockade potentiates the ability of the 5-HT reuptake inhibitor citalopram to increase nerve terminal output of 5-HT in vivo: a microdialysis study","volume":"60","author":"Hjorth","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1016\/j.biopha.2017.10.024_bib0105","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/nrd4075","article-title":"50 years of hurdles and hope in anxiolytic drug discovery. Nature reviews","volume":"12","author":"Griebel","year":"2013","journal-title":"Drug Disc."},{"key":"10.1016\/j.biopha.2017.10.024_bib0110","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0166-4328(02)00311-X","article-title":"Anxiolytic-like effects of 5-HT2 ligands on three mouse models of anxiety","volume":"140","author":"Br\u0131d","year":"2003","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.biopha.2017.10.024_bib0115","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1472-8206.1993.tb01036.x","article-title":"The NMDA receptor complex","volume":"7","author":"Scatton","year":"1993","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.biopha.2017.10.024_bib0120","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/S0028-3908(99)00082-9","article-title":"2-Methyl-6-(phenylethynyl)-pyridine (MPEP), a potent, selective and systemically active mGlu5 receptor antagonist","volume":"38","author":"Gasparini","year":"1999","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.10.024_bib0125","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0022-3565(24)39029-9","article-title":"Anxiolytic-like effects of the prototypical metabotropic glutamate receptor 5 antagonist 2-methyl-6-(phenylethynyl)pyridine in rodents","volume":"295","author":"Spooren","year":"2000","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.biopha.2017.10.024_bib0130","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.neuropharm.2013.01.018","article-title":"Comparison of the effects of the GABAB receptor positive modulator BHF177 and the GABAB receptor agonist baclofen on anxiety-like behavior, learning, and memory in mice","volume":"70","author":"Li","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopha.2017.10.024_bib0135","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/0091-3057(92)90387-U","article-title":"Direct evidence for mediation of anticonflict effect of baclofen by GABAb receptors","volume":"41","author":"Shephard","year":"1992","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2017.10.024_bib0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0014-2999(93)90827-5","article-title":"Handling history of rats modifies behavioral effects of drugs in the elevated plus-maze test of anxiety","volume":"235","author":"Andrews","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.10.024_bib0145","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s002130050148","article-title":"GABAergic influences on plus-maze behavior in mice","volume":"128","author":"Dalvi","year":"1996","journal-title":"Psychoparmacology"},{"key":"10.1016\/j.biopha.2017.10.024_bib0150","doi-asserted-by":"crossref","first-page":"121794","DOI":"10.1155\/2013\/121794","article-title":"Participation of GABAA chloride channels in the anxiolytic-like effects of a fatty acid mixture","volume":"2013","author":"Rodr\u00edguez-Landa","year":"2013","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.biopha.2017.10.024_bib0155","doi-asserted-by":"crossref","first-page":"710410","DOI":"10.1155\/2014\/710410","article-title":"Mikania glomerata Mikania glomerata: Phytochemical, pharmacological, and neurochemical study","volume":"2014","author":"Santana","year":"2014","journal-title":"Evidence-Based Compl. Altern. Med."},{"key":"10.1016\/j.biopha.2017.10.024_bib0160","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12906-016-1048-6","article-title":"Passiflora incarnata Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms","volume":"16","author":"Aman","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.biopha.2017.10.024_bib0165","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.pbb.2006.11.019","article-title":"A possible mechanism for anxiolytic and antidepressant effects of alpha- and beta-amyrin from protium heptaphyllum (aubl.) march","volume":"85","author":"Arag\u00e3o","year":"2006","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.biopha.2017.10.024_bib0170","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1055\/s-2007-981593","article-title":"Bioactivity-guided isolation of beta-sitosterol and some fatty acids as active compounds in the anxiolytic and sedative effects of Tilia americana var. mexicana","volume":"73","author":"Aguirre-Hern\u00e1ndez","year":"2007","journal-title":"Planta Med."},{"key":"10.1016\/j.biopha.2017.10.024_bib0175","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0014-2999(03)01280-9","article-title":"5-HT1A receptor knockout mouse as a genetic model of anxiety","volume":"463","author":"Toth","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.biopha.2017.10.024_bib0180","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.neuropharm.2013.05.030","article-title":"Lower anxiogenic effects of serotonin agonists are associated with lower activation of amygdala and lateral orbital cortex in adolescent male rats","volume":"73","author":"Coburn","year":"2013","journal-title":"Neuropharmacology"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217331335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332217331335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T12:23:18Z","timestamp":1778242998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332217331335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":36,"alternative-id":["S0753332217331335"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.024","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anxiolytic effect of fatty acids and terpenes fraction from Aloysia triphylla: Serotoninergic, GABAergic and glutamatergic implications","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2017.10.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}